id:"swepub:oai:DiVA.org:uu-96869"
Search: id:"swepub:oai:DiVA.org:uu-96869" > Pharmacokinetic con...
- 1 of 1
- Previous record
- Next record
- To hitlist
- Syvänen, StinaUppsala universitet,Institutionen för farmaceutisk biovetenskap,PKPD (author)
Pharmacokinetic consequences of active drug efflux at the blood-brain barrier
- Article/chapterEnglish2006
Publisher, publication year, extent ...
- 2006-04-07
- Springer Science and Business Media LLC,2006
- printrdacarrier
Numbers
- LIBRIS-ID:oai:DiVA.org:uu-96869
- https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-96869URI
- https://doi.org/10.1007/s11095-006-9780-0DOI
Supplementary language notes
- Language:English
- Summary in:English
Part of subdatabase
- SwePubSwePub
Classification
Notes
- PURPOSE: The objective of this simulation study was to investigate how the nature, location, and capacity of the efflux processes in relation to the permeability properties influence brain concentrations. METHODS: Reduced brain concentrations can be due to either influx hindrance, a gatekeeper function in the luminal membrane, which has been suggested for ABCB1 (P-glycoprotein), or efflux enhancement by transporters that pick up molecules on one side of the luminal or abluminal membrane and release them on the other side. Pharmacokinetic models including passive transport, influx hindrance, and efflux enhancement were built using the computer program MATLAB. The simulations were based on experimentally obtained parameters for morphine, morphine-3-glucuronide, morphine-6-glucuronide, and gabapentin. RESULTS: The influx hindrance process is the more effective for keeping brain concentrations low. Efflux enhancement decreases the half-life of the drug in the brain, whereas with influx hindrance the half-life is similar to that seen with passive transport. The relationship between the influx and efflux of the drug across the blood-brain barrier determines the steady-state ratio of brain to plasma concentrations of unbound drug, K(p,uu). CONCLUSIONS: Both poorly and highly permeable drugs can reach the same steady-state ratio, although the time to reach steady state will differ. The volume of distribution of unbound drug in the brain does not influence K(p,uu), but does influence the total brain-to-blood ratio K(p) and the time to reach steady state in the brain.
Subject headings and genre
Added entries (persons, corporate bodies, meetings, titles ...)
- Xie, RuijaUppsala universitet,Institutionen för farmaceutisk biovetenskap,PKPD (author)
- Sahin, SelmaUppsala universitet,Institutionen för farmaceutisk biovetenskap,PKPD (author)
- Hammarlund-Udenaes, MargaretaUppsala universitet,Institutionen för farmaceutisk biovetenskap,PKPD(Swepub:uu)marghamm (author)
- Uppsala universitetInstitutionen för farmaceutisk biovetenskap (creator_code:org_t)
Related titles
- In:Pharmaceutical research: Springer Science and Business Media LLC23:4, s. 705-7170724-87411573-904X
Internet link
Find in a library
- Pharmaceutical research (Search for host publication in LIBRIS)
To the university's database
- 1 of 1
- Previous record
- Next record
- To hitlist
Find more in SwePub
- By the author/editor
- Syvänen, Stina
- Xie, Ruija
- Sahin, Selma
- Hammarlund-Udena ...
- About the subject
-
- MEDICAL AND HEALTH SCIENCES
- MEDICAL AND HEAL ...
- and Basic Medicine
- and Pharmaceutical S ...
- Articles in the publication
- Pharmaceutical r ...
- By the university
- Uppsala University
Search outside SwePub
- Extend your search to:
- Google Book Search
- Google Scholar
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.
- Copyright © LIBRIS - National Library Systems
- LIBRIS.kb.se
